Revobiom
Microbial evolution technology for industrial and research teams developing functional microbial consortia
Highlights
- Young companyFounded 2022
- New on EvolcAdded 2026-11-10
About Revobiom
Revobiom develops the Microbial Evolution Machine (MEM), a platform for screening and evolving microbial strains and communities. It uses droplet-based microfluidics, optical sensors and data-driven monitoring, then supports stabilisation and scale-up of selected consortia.
The company serves industrial and research users seeking microbial functions and non-GMO alternatives. Its work includes industrial trials, including a 2023 trial with Eurogerm to co-evolve yeasts and bacteria for sourdough development.
Founded in 2022, Revobiom is based in Paris and was incubated at ESPCI. Its technology originated in more than 15 years of research at ESPCI; the company reports a team of six and three machines built.
Product: The Microbial Evolution Machine screens and evolves microbial strains and communities, with stabilisation and scale-up support for selected consortia.
Jobs at Revobiom
Leadership
- Thomas Bibette · CEO & Co-FounderSource: company website
- Wilfried Sire · CTO & Co-FounderSource: company website
More biotech & pharma companies
Rime Bioinformatics
Genomic analyses and custom bioinformatics tools for phage therapy, fermentation and microbiome R&D teamsNew on EvolcRoche
Pharmaceutical drugs and diagnostic solutions for patients and healthcare professionals in FranceRoowin
Fine chemistry and cGMP drug-development services for pharmaceutical, biotechnology, and fine chemical companiesNew on EvolcSanofi
Biopharmaceutical company developing medicines and vaccines for patients, with France as its main R&D and industrial baseNew on EvolcSanten
Develops and supplies ophthalmic medicines and eye-care products for patients and healthcare professionalsNew on EvolcScilicium
Bioinformatics services and omics analysis for cosmetics and life-sciences research teamsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- WebflowHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.